九基因表达分类器(ONEX)鉴别良性肾嗜酸细胞瘤
研究开发基于九个差异表达基因的分类器,用于区分良性肾嗜酸细胞瘤(RO)与嫌色细胞肾细胞癌(chRCC)及其他恶性模拟病变。 classifier在五个独立验证队列共89例中区分RO与chRCC的敏感性93%、特异性98%,c统计量0.978。该工具可能辅助减少小肾肿块诊断不确定性,帮助更自信地推荐低侵袭性管理。
要点
- 九基因分类器区分RO与chRCC敏感性93%、特异性98%。
- 验证队列合并c统计量0.978,支持高鉴别效能。
- 可能辅助避免对良性RO的不必要手术。
核心结论
- 九基因表达分类器在验证队列中高准确区分肾嗜酸细胞瘤与嫌色细胞肾细胞癌。
研究设计与样本
- 发现队列44例鉴定九个差异表达基因,训练队列57例,五个独立验证队列共89例。
主要发现
- RO相对chRCC有九个基因差异丰度显著。
- 合并验证队列区分RO与chRCC敏感性93%、特异性98%、c统计量0.978。
关键数值与推荐
- RO占肾癌5%,通常良性且长期预后良好。
- 九基因分类器验证敏感性93%、特异性98%、c统计量0.978。
临床怎么用
- 可作为其他诊断方式的辅助工具,减少小肾肿块诊断与管理不确定性。
- 帮助临床医生更自信地对部分肿瘤推荐低侵袭性管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Renal oncocytoma (RO) accounts for 5% of renal cancers and generally behaves as a benign tumor with favorable long-term prognosis. It is difficult to confidently distinguish between benign RO and other renal malignancies, particularly chromophobe renal cell carcinoma (chRCC). Therefore, RO is often managed aggressively with surgery. We sought to identify molecular biomarkers to distinguish RO from chRCC and other malignant renal cancer mimics. In a 44-patient discovery cohort, we identified a significant differential abundance of nine genes in RO relative to chRCC. These genes were used to train a classifier to distinguish RO from chRCC in an independent 57-patient cohort. The trained classifier was then validated in five independent cohorts comprising 89 total patients. This nine-gene classifier trained on the basis of differential gene expression showed 93% sensitivity and 98% specificity for distinguishing RO from chRCC across the pooled validation cohorts, with a c-statistic of 0.978. This tool may be a useful adjunct to other diagnostic modalities to decrease the diagnostic and management uncertainty associated with small renal masses and to enable clinicians to recommend more confidently less aggressive management for some tumors. PATIENT SUMMARY: Renal oncocytoma is generally a benign form of kidney cancer that does not necessarily require surgical removal. However, it is difficult to distinguish renal oncocytoma from other more aggressive forms of kidney cancer, so it is treated most commonly with surgery. We built a classification tool based on the RNA levels of nine genes that may help avoid these surgeries by reliably distinguishing renal oncocytoma from other forms of kidney cancer.
引用
- McGillivray PD, Ueno D, Pooli A, et al. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier. Eur Urol. 2020. PMID: 32972793. doi:10.1016/j.eururo.2020.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。